Poster 1024-P: effect of tirzepatide, a dual GIP and GLP-1 receptor agonist, on glycemic control and body weight in Japanese patients with T2DM. Diabetes 2019;68(1) - Ohwaki, K; Furihata, K; Mimura, M
et al.